Medirect Latino Inc (Other) (8-K)
27 Setembro 2007 - 6:30PM
Edgar (US Regulatory)
____________________________________________________
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
___________
FORM
8-K
___________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
Date
of Report (Date of earliest reported):
September 27,
2007
|
|
|
|
MEDirect
Latino, Inc.
|
|
(Exact
name of small business issuer as specified in its
charter)
|
|
|
|
|
|
Florida
|
000-51795
|
20-1327083
|
|
(State
or other jurisdiction of Incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
Number)
|
2101
West Atlantic Boulevard, Suite 101, Pompano Beach, FL
33069
(Address
of principal executive offices)
954-321-3540
(Registrant’s
telephone number, including area code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2.)
[
] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[
] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
[
]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
|
[
]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Item:
8.01 Other Events
The
Company has received a request from a Medicare program safeguard contractor
to
produce medical and other ordering and shipping records for thirty Company
customers that received diabetic testing supplies and/or home medical equipment
over the last several years. The Company has no information
indicating that it is the target or subject of any governmental investigation
at
this time. In connection with the collection of medical records and
other information required to be furnished in the request by the program
contractor, the Company identified a material number of files in which the
required Medicare ordering documentation is not complete or is
missing.
Based
upon the preliminary findings of the thirty files initially reviewed, the
Company has initiated an internal investigation beyond the thirty records
requested by the Medicare program safeguard contractor. The
investigation is being supervised by a Special Investigation Committee made
up
of independent members of the Board of Directors. If a material
percentage of document deficiencies is found by the internal investigation,
the
Company may be required to refund amounts previously paid to it by Medicare
or
to self-disclose its findings to the appropriate federal
authorities.
The
total amount of any refunds cannot
be quantified at this time, but, given the Company’s current financial
situation, any significant refunds due to Medicare could have material adverse
effect on the Company and/or its operations. In addition, any
material Medicare recovery against the Company may adversely impact the
Company’s ability to participate in the Medicare DMEPOS competitive bidding
authority implementation.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
MEDirect
Latino, Inc.
|
|
|
|
|
|
|
|
Dated:
September
27, 2007
|
By:
|
/s/ Charles
W. Hansen
III
|
|
|
|
|
Charles
W. Hansen III
|
|
|
|
|
CEO
|
|
|
|
|
|
|
Medirect Latino (CE) (USOTC:MLTO)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Medirect Latino (CE) (USOTC:MLTO)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
